Literature DB >> 16927401

The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.

Gabriella Künig1, Michael Jäger, Volker Stief, Andreas Kaldune, Frank Urbaniok, Jerome Endrass.   

Abstract

OBJECTIVES: To identify the most appropriate test combination for distinguishing between late onset depression (LOD) and Alzheimer's disease (AD). To achieve this objective, the Consortium to Establish a Register for Alzheimer's Disease-Neuropsychological Battery (CERAD-NP) data of patients diagnosed with these two conditions were analyzed using multiple regression analysis.
METHODS: In the first regression analysis, the following CERAD-NP subtests were included: verbal fluency, Boston naming test, word list learning, constructional praxis, word list recall, and constructional praxis recall. In a second regression analysis, only CERAD-NP memory parameters were included: word list learning, word list recall, word list intrusions, word list savings, word list recognition, word list false positive errors, constructional praxis recall, and constructional praxis savings.
RESULTS: The combination of word list recall and constructional praxis recall best distinguished between LOD and AD, with a ROC of 0.91. In the stepwise regression of memory measures, word list recall, word list savings, and constructional praxis recall was the best combination, resulting in a ROC of 0.92.
CONCLUSION: The most efficacious combination of the CERAD-NP battery for discriminating between LOD and AD consisted of word list recall and constructional praxis recall. Of the CERAD-NP memory measures, word list recall, word list savings, and constructional praxis recall represented the best diagnostic combination. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16927401     DOI: 10.1002/gps.1579

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  7 in total

1.  Neuropsychological indicators of preclinical Alzheimer's disease among depressed older adults.

Authors:  Nicole C Rushing; Natalie Sachs-Ericsson; David C Steffens
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2013-05-09

2.  Norms for CERAD constructional praxis recall.

Authors:  Gerda G Fillenbaum; Bruce M Burchett; Frederick W Unverzagt; Daniel F Rexroth; Kathleen Welsh-Bohmer
Journal:  Clin Neuropsychol       Date:  2011-10-13       Impact factor: 3.535

3.  Neuropsychological predictors of dementia in late-life major depressive disorder.

Authors:  Guy G Potter; H Ryan Wagner; James R Burke; Brenda L Plassman; Kathleen A Welsh-Bohmer; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2013-03       Impact factor: 4.105

4.  The Newly Normed SKT Reveals Differences in Neuropsychological Profiles of Patients with MCI, Mild Dementia and Depression.

Authors:  Hartmut Lehfeld; Mark Stemmler
Journal:  Diagnostics (Basel)       Date:  2019-10-25

5.  Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease Continuum.

Authors:  Felix Menne; Carola Gertrud Schipke; Arne Klostermann; Manuel Fuentes-Casañ; Silka Dawn Freiesleben; Chris Bauer; Oliver Peters
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

6.  Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression.

Authors:  Irene R Beck; Nicole S Schmid; Manfred Berres; Andreas U Monsch
Journal:  Int J Geriatr Psychiatry       Date:  2013-11-14       Impact factor: 3.485

7.  Neurogranin and BACE1 in CSF as Potential Biomarkers Differentiating Depression with Cognitive Deficits from Early Alzheimer's Disease: A Pilot Study.

Authors:  Carola G Schipke; Ann De Vos; Manuel Fuentes; Dirk Jacobs; Eugeen Vanmechelen; Oliver Peters
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2018-08-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.